# EXPAREL Dose-Response for Single-Injection Femoral Nerve Blocks

> **NCT01349140** · PHASE1 · COMPLETED · sponsor: **University of California, San Diego** · enrollment: 14 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** SKY0402

## Key facts

- **NCT ID:** NCT01349140
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2021-03-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01349140

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01349140, "EXPAREL Dose-Response for Single-Injection Femoral Nerve Blocks". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01349140. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*